Shares of other companies:
Wall Street Brunch: Here Comes Nvidia
May 19, 2024
A.O. Smith: Great Company, Inferior Investment
May 18, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
ALGN Stock News and Mentions of Align Technology, Inc. Stocktwits
Updated: May 20, 2024 (09:13)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Align Technology Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Align Technology, Inc. (ALGN).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Align Technology stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Align Technology, Inc. (ALGN)
May 17, 2024 (19:20) / "Benzinga" (by Zacks)
HealthEquity Closes Conduent's BenefitWallet Acquisition - Boston Scientific ( NYSE:BSX ) , Align Tech ( NASDAQ:ALGN )
HealthEquity HQY recently announced the completion of the acquisition of Conduent's BenefitWallet Health Savings Account portfolio. In September 2023, HealthEquity entered into an agreement to acquire the BenefitWallet HSA portfolio from Conduent Business Services, LLC
In Article Trend: Somewhat-Bullish
May 17, 2024 (16:33) / "Zacks Commentary" (by Zacks Equity Research)
Veeva's ( VEEV ) Vault Basics to Boost Efficiency for Biotechs
Veeva (VEEV) announces the availability of Vault Basics for biotechs, which aims to deliver complete and pre-validated solutions for expanding businesses.
In Article Trend: Somewhat-Bullish
May 17, 2024 (16:29) / "Zacks Commentary" (by Zacks Equity Research)
AxoGen ( AXGN ) Initiates BLA Submission for Avance Nerve Graft
AxoGen (AXGN) starts the process of BLA submission to the FDA for the approval of its Avance Nerve Graft.
In Article Trend: Neutral
May 17, 2024 (11:05) / "Zacks Commentary" (by Zacks Equity Research)
Reasons to Retain DexCom ( DXCM ) Stock in Your Portfolio Now
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
In Article Trend: Bullish
May 16, 2024 (18:13) / "Zacks Commentary" (by Zacks Equity Research)
Butterfly Network ( BFLY ) Unveils iQ+ Bladder Ultrasound Scanner
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
In Article Trend: Bullish
May 16, 2024 (17:25) / "Zacks Commentary" (by Zacks Equity Research)
HealthEquity ( HQY ) Closes Conduent's BenefitWallet Acquisition
HealthEquity (HQY) completes the acquisition of Conduent's BenefitWallet HSA portfolio. This is likely to further strengthen the HSA business of HealthEquity.
In Article Trend: Somewhat-Bullish
May 16, 2024 (15:43) / "Zacks Commentary" (by Zacks Equity Research)
Align Technology ( ALGN ) Gains From Innovation, Global Expansion
In the United States, Align Technology (ALGN) is focused on reaching young adults as well as teens and their parents through famous athletes, influencers and fashion designers.
In Article Trend: Somewhat-Bullish
May 16, 2024 (13:18) / "Zacks Commentary" (by Zacks Equity Research)
Profound Medical ( PROF ) Adds AI to Prostate Cancer Treatment
Profound Medical's (PROF) Contouring Assistant integrates AI into prostate cancer procedures, thereby streamlining the treatment planning process and enhancing both efficiency and precision.
In Article Trend: Somewhat-Bullish
May 15, 2024 (20:01) / "Business Insider" (by Zacks)
Philips' Gets FDA Recall for Trilogy Ventilator Glitch
Koninklijke Philips ( NYSE:PHG ) notified its customers about a possible power malfunction in its Trilogy Evo continuous ventilators and initiated a software update to resolve the same in March.
In Article Trend: Neutral
May 15, 2024 (19:36) / "Benzinga" (by Zacks)
Philips' Gets FDA Recall for Trilogy Ventilator Glitch - Boston Scientific ( NYSE:BSX ) , Align Tech ( NASDAQ:ALGN )
Koninklijke Philips PHG notified its customers about a possible power malfunction in its Trilogy Evo continuous ventilators and initiated a software update to resolve the same in March.
In Article Trend: Neutral
May 15, 2024 (16:09) / "Zacks Commentary" (by Zacks Equity Research)
Reasons to Add Veeva Systems ( VEEV ) Stock to Your Portfolio
Veeva System's (VEEV) strong product demand and strategic deals raise optimism about the stock.
In Article Trend: Somewhat-Bullish
May 15, 2024 (16:08) / "Zacks Commentary" (by Zacks Equity Research)
GE HealthCare ( GEHC ) , Medis Medical Partner to Aid CAD Therapy
GE HealthCare (GEHC) and Medis Medical collaborate to boost precision care for coronary artery disease treatment.
In Article Trend: Somewhat-Bullish
May 15, 2024 (14:49) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Buy Align Technology ( ALGN ) Stock Now
Investors are optimistic about Align Technology (ALGN) led by expansion in new geographies and upbeat guidance.
In Article Trend: Somewhat-Bullish
May 15, 2024 (13:41) / "Zacks Commentary" (by Urmimala Biswas)
3 Solid Buys From MedTech Following 2024 Guidance Raise
Guidance hikes by BSX, ALGN and ALC for 2024 make them attractive investment bets.
In Article Trend: Bullish
May 15, 2024 (12:55) / "Zacks Commentary" (by Zacks Equity Research)
Senseonics' ( SENS ) Deal With Mercy to Drive Eversense CGM Sales
Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.
In Article Trend: Bullish
May 15, 2024 (11:32) / "Zacks Commentary" (by Zacks Equity Research)
Stereotaxis ( STXS ) Inks Deal to Buy Access Point Technologies
Stereotaxis' (STXS) deal to acquire electrophysiology catheter developer, Access Point Technologies, is likely to strengthen its position within the catheter market.
In Article Trend: Somewhat-Bullish
May 14, 2024 (16:13) / "Zacks Commentary" (by Zacks Equity Research)
Philips' ( PHG ) Gets FDA Recall for Trilogy Ventilator Glitch
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
In Article Trend: Neutral
May 14, 2024 (10:51) / "Zacks Commentary" (by Zacks Equity Research)
Reasons to Add The Cooper Companies ( COO ) to Your Portfolio
The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning.
In Article Trend: Somewhat-Bullish
May 13, 2024 (16:06) / "Zacks Commentary" (by Zacks Equity Research)
Reasons to Retain Intuitive Surgical ( ISRG ) in Your Portfolio
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
In Article Trend: Somewhat-Bullish
May 13, 2024 (15:18) / "Zacks Commentary" (by Zacks Equity Research)
Orthofix Medical's ( OFIX ) Telescopic Nail Gets FDA Clearance
Orthofix Medical (OFIX) announces the FDA clearance of its Rodeo Telescopic Nail, which is likely to aid in curing fractures or abnormalities in individuals with osteogenesis imperfecta.
In Article Trend: Somewhat-Bullish
May 10, 2024 (15:38) / "Zacks Commentary" (by Zacks Equity Research)
Neogen ( NEOG ) Faces Macroeconomic Issues, Fierce Competition
Neogen (NEOG) faces intense competition from companies ranging from small businesses to divisions of large multinational companies.
In Article Trend: Somewhat-Bullish
May 10, 2024 (15:17) / "Zacks Commentary" (by Zacks Equity Research)
AMN Healthcare ( AMN ) Q1 Earnings and Revenues Beat Estimates
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
In Article Trend: Neutral
May 10, 2024 (15:16) / "Zacks Commentary" (by Zacks Equity Research)
PacBio ( PACB ) Q1 Earnings In Line, Adjusted Gross Margin Up
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.
In Article Trend: Neutral
May 9, 2024 (17:31) / "Zacks Commentary" (by Zacks Equity Research)
Catalent ( CTLT ) Q3 Earnings Lag Estimates, Gross Margin Up
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
In Article Trend: Neutral
May 9, 2024 (17:29) / "Zacks Commentary" (by Zacks Equity Research)
Inogen ( INGN ) Q1 Earnings Top Estimates, Revenues Up Y/Y
Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
In Article Trend: Neutral
May 9, 2024 (17:28) / "Zacks Commentary" (by Zacks Equity Research)
QuidelOrtho ( QDEL ) Q1 Earnings Beat Estimates, Margins Fall
QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.
In Article Trend: Neutral
May 9, 2024 (13:59) / "Benzinga" (by Zacks)
Inspire Medical Q1 Earnings Beat, Gross Margin Up - Boston Scientific ( NYSE:BSX ) , Align Tech ( NASDAQ:ALGN )
Inspire Medical Systems, Inc. INSP delivered a loss per share of 34 cents in first-quarter 2024, narrower than the year-ago period's loss of 53 cents per share. The metric was also narrower than the Zacks Consensus Estimate of a loss of 63 cents per share.
In Article Trend: Somewhat-Bullish
May 9, 2024 (13:18) / "Zacks Commentary" (by Zacks Equity Research)
OPKO Health's ( OPK ) Q1 Earnings Miss Estimates, Sales Down Y/Y
OPKO Health's (OPK) first-quarter results reflect soft performances despite robust RAYALDEE sales and strength in the Pharmaceuticals segment.
In Article Trend: Neutral
May 8, 2024 (16:43) / "Zacks Commentary" (by Zacks Equity Research)
McKesson ( MCK ) Q4 Earnings Miss Estimates, Revenues Up Y/Y
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
In Article Trend: Neutral
May 8, 2024 (16:14) / "Zacks Commentary" (by Zacks Equity Research)
Nevro's ( NVRO ) Q1 Earnings and Sales Beat Estimates, Margins Up
Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.
In Article Trend: Neutral
May 8, 2024 (15:33) / "Zacks Commentary" (by Zacks Equity Research)
Inspire Medical ( INSP ) Q1 Earnings Beat, Gross Margin Up
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.
In Article Trend: Somewhat-Bullish
May 8, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)
Masimo ( MASI ) Q1 Earnings Beat Estimates, '24 EPS View Up
Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.
In Article Trend: Neutral
May 8, 2024 (15:23) / "Zacks Commentary" (by Zacks Equity Research)
Fresenius Medical ( FMS ) Q1 Earnings Beat, Operating Margin Up
Fresenius Medical's (FMS) first-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.
In Article Trend: Somewhat-Bullish
May 7, 2024 (15:33) / "Zacks Commentary" (by Zacks Equity Research)
Integra's ( IART ) Q1 Earnings Match Estimates, Margins Down
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
In Article Trend: Neutral
May 7, 2024 (15:23) / "Zacks Commentary" (by Zacks Equity Research)
Quest Diagnostics ( DGX ) Grows in Digital Pathology With New Deal
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
In Article Trend: Somewhat-Bullish
May 7, 2024 (14:27) / "Zacks Commentary" (by Zacks Equity Research)
Shockwave Medical ( SWAV ) Q1 Earnings Beat, Revenues Rise Y/Y
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion amid JNJ entering into a definitive agreement to acquire the company.
In Article Trend: Somewhat-Bullish
May 7, 2024 (12:19) / "Zacks Commentary" (by Zacks Equity Research)
GE HealthCare ( GEHC ) Unveils Head-Only MR Scanner SIGNA MAGNUS
GE HealthCare's (GEHC) new SIGNA MAGNUS can delve deep into the brain's microstructure, microvasculature and function, providing researchers with a clearer picture of neurological diseases and disorders.
In Article Trend: Somewhat-Bullish
May 6, 2024 (13:40) / "Zacks Commentary" (by Zacks Equity Research)
Is Align Technology ( ALGN ) Outperforming Other Medical Stocks This Year?
Here is how Align Technology (ALGN) and Aadi Bioscience, Inc. (AADI) have performed compared to their sector so far this year.
In Article Trend: Somewhat-Bullish
May 3, 2024 (17:14) / "Zacks Commentary" (by Zacks Equity Research)
Avanos ( AVNS ) Q1 Earnings & Revenues Surpass Estimates
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
In Article Trend: Neutral
May 3, 2024 (17:12) / "Zacks Commentary" (by Zacks Equity Research)
Surmodics ( SRDX ) Q2 Earnings Top Estimates, '24 View Up
Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.
In Article Trend: Neutral
May 3, 2024 (16:29) / "Zacks Commentary" (by Zacks Equity Research)
Hologic's ( HOLX ) Q2 Earnings Beat Estimates, 2024 View Up
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
In Article Trend: Neutral
May 3, 2024 (16:24) / "Zacks Commentary" (by Zacks Equity Research)
Lantheus ( LNTH ) Q1 Earnings Surpass Estimates, Gross Margin Up
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
In Article Trend: Neutral
May 3, 2024 (16:22) / "Zacks Commentary" (by Zacks Equity Research)
DaVita ( DVA ) Q1 Earnings & Revenues Top Estimates, Margins Up
DaVita's (DVA) robust segmental revenues drive its first-quarter performance.
In Article Trend: Neutral
May 3, 2024 (16:22) / "Zacks Commentary" (by Zacks Equity Research)
Bruker ( BRKR ) Q1 Earnings Surpass Estimates, Margins Decline
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.
In Article Trend: Neutral
May 3, 2024 (16:13) / "Zacks Commentary" (by Zacks Equity Research)
Teleflex ( TFX ) Q1 Earnings Beat Estimates, Margins Rise
Teleflex's (TFX) first-quarter 2024 results reflect growth across the majority of the company's product families in EMEA.
In Article Trend: Neutral
May 3, 2024 (13:53) / "Zacks Commentary" (by Zacks Equity Research)
GE Healthcare's ( GEHC ) Revolution RT to Aid Cancer Treatment
GE Healthcare (GEHC) unveils Revolution RT, along with other upgrades, from its portfolio during the ESTRO 2024 Congress.
In Article Trend: Somewhat-Bullish
May 3, 2024 (08:12) / "Motley Fool" (by Motley Fool Staff)
IBM's Deal and Meta's Report
How could IBM's buying HashiCorp help it? And what was it about Meta's earnings report that gave the market pause?
In Article Trend: Somewhat-Bullish
May 2, 2024 (17:05) / "Zacks Commentary" (by Zacks Equity Research)
DENTSPLY SIRONA ( XRAY ) Q1 Earnings In Line, Revenues Decline Y/Y
DENTSPLY SIRONA's (XRAY) first-quarter 2024 results showcase a decline in year-over-year sales with an improved bottom line.
In Article Trend: Neutral
May 2, 2024 (15:54) / "Zacks Commentary" (by Zacks Equity Research)
Zimmer Biomet ( ZBH ) Q1 Earnings Beat, Margins Expand
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
In Article Trend: Somewhat-Bullish
May 2, 2024 (14:54) / "Zacks Commentary" (by Zacks Equity Research)
Envista ( NVST ) Q1 Earnings Miss Estimates, Margins Down
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
In Article Trend: Neutral
May 2, 2024 (14:42) / "Zacks Commentary" (by Zacks Equity Research)
Reasons to Retain Quest Diagnostics ( DGX ) Stock for Now
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
In Article Trend: Somewhat-Bullish
May 2, 2024 (14:03) / "Zacks Commentary" (by Zacks Equity Research)
Cardinal Health ( CAH ) Beats on Q3 Earnings, Ups '24 EPS View
Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
In Article Trend: Somewhat-Bullish
May 2, 2024 (14:03) / "Zacks Commentary" (by Zacks Equity Research)
Baxter ( BAX ) Q1 Earnings Beat Estimates, '24 EPS View Raised
Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products.
In Article Trend: Somewhat-Bullish
May 2, 2024 (13:25) / "Zacks Commentary" (by Zacks Equity Research)
BD ( BDX ) Q2 Earnings Surpass Estimates, FY24 View Revised
BD's (BDX) overall top line benefits from revenue growth in all segments and both geographic regions in the fiscal second quarter.
In Article Trend: Somewhat-Bullish
May 2, 2024 (13:16) / "Zacks Commentary" (by Zacks Equity Research)
Accuray ( ARAY ) Q3 Earnings Lag Estimates, Gross Margin Contracts
Despite strength in radiation oncology, Accuray (ARAY) reports dismal third-quarter fiscal 2024 results.
In Article Trend: Neutral
May 2, 2024 (13:14) / "Zacks Commentary" (by Zacks Equity Research)
Glaukos ( GKOS ) Q1 Earnings Miss Estimates, Revenues Up Y/Y
Glaukos' (GKOS) first-quarter 2024 results showcase growth in revenues while earnings miss the Zacks consensus Estimate. Loss at the operating level raises concern as well.
In Article Trend: Neutral
May 1, 2024 (16:47) / "Zacks Commentary" (by Zacks Equity Research)
Merit Medical ( MMSI ) Q1 Earnings Top Estimates, Margins Up
Merit Medical (MMSI) benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter.
In Article Trend: Somewhat-Bullish
May 1, 2024 (15:16) / "Zacks Commentary" (by Zacks Equity Research)
CVS Health's ( CVS ) Q1 Earnings Miss Estimates, Margins Up
CVS Health's (CVS) Q1 performance is impacted by a decline in the Health Services segment due to continued pharmacy client price improvements.
In Article Trend: Neutral
May 1, 2024 (14:59) / "Zacks Commentary" (by Zacks Equity Research)
Inari Medical ( NARI ) Q1 Earnings Miss Estimates, OpEx Rises
Inari Medical's (NARI) first-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the companies continue to incur operating losses.
In Article Trend: Somewhat-Bullish
May 1, 2024 (13:13) / "Zacks Commentary" (by Zacks Equity Research)
Stryker's ( SYK ) Q1 Earnings Beat Estimates, Guidance Raised
Stryker's (SYK) first-quarter earnings reflect strong performance across its segments and geographies. Operating and gross margins increase, with earnings and revenues beating their respective estimates.
In Article Trend: Somewhat-Bullish
May 1, 2024 (12:44) / "Zacks Commentary" (by Zacks Equity Research)
Cencora ( COR ) Q2 Earnings Top Estimates, 2024 View Raised
Cencora's (COR) second-quarter fiscal 2024 results benefit from overall market growth, including rising demand for GLP-1 drugs and COVID-19 vaccines. Inflationary pressure remains.
In Article Trend: Somewhat-Bullish
April 30, 2024 (16:35) / "Zacks Commentary" (by Zacks Equity Research)
Ecolab ( ECL ) Q1 Earnings Surpass Estimates, Margins Rise
Ecolab's (ECL) robust performance across the majority of its segments drives its first-quarter sales despite business challenges.
In Article Trend: Neutral
April 30, 2024 (16:26) / "Zacks Commentary" (by Zacks Equity Research)
QIAGEN ( QGEN ) Q1 Earnings Top Estimates, Margins Expand
QIAGEN (QGEN) Q1 results are driven by solid growth in consumables and ongoing higher instruments placements.
In Article Trend: Neutral
April 30, 2024 (15:44) / "Zacks Commentary" (by Zacks Equity Research)
Philips ( PHG ) Q1 Earnings Beat Estimates, Revenues Fall Y/Y
Philips' (PHG) first-quarter results benefit from strong momentum across the Diagnosis & Treatment and Personal Health businesses. However, softness in the Connected Care business is a concern.
In Article Trend: Neutral
April 29, 2024 (21:07) / "Business Insider" (by Joey Frenette)
Cutting Edge Picks: 3 Med Tech Stocks With Room to Run
Undoubtedly, investors seem to have a new appetite for next-level revenue growth. Generative AI, GLP-1 weight-loss drugs and other breakthrough innovations ( I'm not sure if the metaverse qualifies right now ) seek to expand in some pretty massive markets.
In Article Trend: Somewhat-Bullish
April 29, 2024 (16:33) / "Zacks Commentary" (by Zacks Equity Research)
Avantor ( AVTR ) Q1 Earnings Surpass Estimates, Margins Down
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.
In Article Trend: Neutral
April 26, 2024 (17:07) / "Zacks Commentary" (by Zacks Equity Research)
Integer Holdings ( ITGR ) Q1 Earnings Top Estimates, Margins Up
Integer Holdings' (ITGR) first-quarter results reflect robust Medical Sales, along with strength in all the product lines.
In Article Trend: Neutral
April 26, 2024 (13:23) / "GlobeNewswire" (by Tevogen Bio Inc)
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
• Conversion of promissory notes into common stock removed $94.9 million in pro forma balance sheet liabilities. • The converted common stock is included in the company's total 165 million outstanding shares. • The Tevogen.ai initiative aims to harness the immense potential of AI to enhance drug ...
In Article Trend: Somewhat-Bullish
April 26, 2024 (07:00) / "Investors Business Daily" (by Investor's Business Daily)
Align Technology Hits 80-Plus Relative Strength Rating Benchmark
On Friday, Align Technology ( ALGN ) hit an important technical milestone, with its Relative Strength ( RS ) Rating moving into the 80-plus percentile with an upgrade to 81, up from 68 the day before. X This exclusive rating from Investor's Business Daily identifies market leadership with a 1 ...
In Article Trend: Somewhat-Bullish
April 25, 2024 (17:41) / "Zacks Commentary" (by Zacks Equity Research)
Align Technology ( ALGN ) Q1 Earnings Top, 2024 Sales View Up
Align Technology's (ALGN) first quarter 2024 revenue growth was up across all regions and was driven by strong Clear Aligner volumes, primarily in the Asia Pacific region.
In Article Trend: Somewhat-Bullish
April 25, 2024 (03:00) / "Motley Fool" (by Motley Fool Transcribing)
Align Technology ( ALGN ) Q1 2024 Earnings Call Transcript
ALGN earnings call for the period ending March 31, 2024.
In Article Trend: Somewhat-Bullish
April 24, 2024 (21:10) / "Zacks Commentary" (by Zacks Equity Research)
Align Technology ( ALGN ) Surpasses Q1 Earnings and Revenue Estimates
Align Technology (ALGN) delivered earnings and revenue surprises of 8.08% and 2.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Somewhat-Bullish
April 23, 2024 (15:36) / "Zacks Commentary" (by Zacks Equity Research)
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
In Article Trend: Somewhat-Bullish
April 22, 2024 (19:24) / "Forbes" (by Angelica Mari)
LinkedIn Ranks Kyndryl As Brazil's Best Tech Employer
LinkedIn has announced a list of Brazil's best technology employers, with IBM's IT infrastructure spin off Kyndryl ranked as the number one company to work for. The list classifies companies into eight categories as indicators of career development using LinkedIn data.
In Article Trend: Somewhat-Bullish
April 22, 2024 (13:16) / "Zacks Commentary" (by Zacks Equity Research)
What Analyst Projections for Key Metrics Reveal About Align Technology ( ALGN ) Q1 Earnings
Get a deeper insight into the potential performance of Align Technology (ALGN) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
In Article Trend: Somewhat-Bullish
April 22, 2024 (13:01) / "Zacks Commentary" (by Zacks Equity Research)
Zacks Investment Ideas feature highlights: Vertiv, Align Technology and DexCom
Vertiv, Align Technology and DexCom are part of the Zacks Investment Ideas article.
In Article Trend: Neutral
April 19, 2024 (23:20) / "PR Newswire"
Clear aligners market to grow by USD 8.97 billion from 2022 to 2027, Technavio - PR Newswire
Clear aligners market to grow by USD 8.97 billion from 2022 to 2027, Technavio PR ...
In Article Trend: Bullish
April 19, 2024 (11:00) / "Zacks Commentary" (by Benjamin Rains)
3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
Long-term investors are often well-served to buy stocks amid bouts of weakness.
In Article Trend: Neutral
April 18, 2024 (13:40) / "Zacks Commentary" (by Zacks Equity Research)
Is Ayr Wellness Inc. ( AYRWF ) Stock Outpacing Its Medical Peers This Year?
Here is how Ayr Wellness Inc. (AYRWF) and Align Technology (ALGN) have performed compared to their sector so far this year.
In Article Trend: Somewhat-Bullish
April 16, 2024 (21:31) / "PR Newswire" (by LLP)
Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering market growth.
In Article Trend: Somewhat-Bullish
April 16, 2024 (15:51) / "Zacks Commentary" (by Zacks Equity Research)
Align Technology ( ALGN ) to Post Q1 Earnings: What's in Store?
Align Technology's (ALGN) first-quarter 2024 performance is likely to reflect the strength of the Clear Aligner and Systems & Services businesses.
In Article Trend: Somewhat-Bullish
April 10, 2024 (15:10) / "Zacks Commentary" (by Zacks Equity Research)
Align Technology ( ALGN ) Up 20.5% YTD: Will the Rally Continue?
Investors are optimistic about Align Technology (ALGN) driven by geographic expansion and upbeat guidance.
In Article Trend: Somewhat-Bullish
April 2, 2024 (13:40) / "Zacks Commentary" (by Zacks Equity Research)
Is Align Technology ( ALGN ) Stock Outpacing Its Medical Peers This Year?
Here is how Align Technology (ALGN) and atai Life Sciences N.V. (ATAI) have performed compared to their sector so far this year.
In Article Trend: Somewhat-Bullish
March 26, 2024 (12:44) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Buy Align Technology ( ALGN ) Stock Now
Investors remain optimistic about Align Technology (ALGN), backed by Invisalign's strong potential and impressive collaborations.
In Article Trend: Somewhat-Bullish
March 25, 2024 (13:00) / "PR Newswire" (by PathKeeper)
PathKeeper Surgical enters into know-how agreement with Mayo Clinic for low-radiation pediatric spine surgery
PathKeeper Surgical enters a know-how agreement with Mayo Clinic in Rochester, MN. The development will focus on reduction of pediatric patient radiation exposure and measurements of deformity correction using optical navigation
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website